SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE UVEORETINITIS BY NEUROPEPTIDE GENE-TRANSFECT-CELLS

神经肽基因转染细胞抑制实验性自身免疫性葡萄膜视网膜炎

基本信息

  • 批准号:
    17591855
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

To investigate the role of the suppression in murine experimental autoimmune uveoretinitis (EAU) by mature dendritic cells (DC) cultured with calcitonin gene-related peptide (CGRP). Bone marrow cells derived from C57BL/6 mice were cultured with GM-CSF for six days, and differentiated CD11^+ immature DC were purified by autoMACS. Immature DC were further cultured with LPS (1 μg/ml) overnight, and then with human interphotoreceptor retinoid binding protein (IRBP) residues 1-20 (hIRBP-p) in the presence of CGRP or TGF-B2. EAU was induced by immunization with hIRBP-p in Freund' s adjuvant and pertussis toxin in mice. At the same time, hIRBP-p-immunized mice were injected the mature DC cultured with CGRP or TGF-B2 intravenously. On day 19 after immunization, hIRBP-p-specific delayed hypersensitivity (DH) were measured. On day 21 after immunization, animals were sacrificed, and assessed the extent of EAU pathologically. EAU and antigen-specific DH was predominantly suppressed by injection of mature DC cultured with CGRP or TGF-B2 and hIRBP-p. Incidence of EAU on control group was 87% (13 of 15 EAU mice), TGF-B2 culture group was 60% (9 of 15 EAU mice), and CGRP culture group was 28% (5 of 18 EAU mice). On the next experiments, we prepared CGRP gene-transfect-DC by electroporation methods. As the results, CGRP gene-transfect-DC can suppress EAU, and suppress DH spepific for IRBP-p. It was demonstrated that mature DC cultured with CGRP and CGRP gene-transfect-DC play an immunosuppressive role in development of EAU, which were more effective than those cultured with TGF-B2.
目的探讨降钙素基因相关肽(CGRP)诱导的成熟树突状细胞(DC)对小鼠实验性自身免疫性葡萄膜视网膜炎(EAU)的抑制作用。将C57 BL/6小鼠的骨髓细胞与GM-CSF培养6天,用autoMACS纯化分化的CD 11 ^+未成熟DC。将未成熟DC与LPS(1 μg/ml)进一步培养过夜,然后在CGRP或TGF-β 2存在下与人光感受器间类视黄醇结合蛋白(IRBP)残基1-20(hIRBP-p)培养。通过用在弗氏佐剂中的hIRBP-p和百日咳毒素在小鼠中免疫诱导EAU。同时,将CGRP或TGF-β 2诱导的成熟DC静脉注射hIRBP-p免疫小鼠。在免疫后第19天,测量hIRBP-p特异性迟发型超敏反应(DH)。在免疫后第21天,处死动物,并对EAU的程度进行病理学评估。对照组EAU发生率为87%(13/15),TGF-B2培养组为60%(9/15),CGRP培养组为28%(5/18)。在接下来的实验中,我们采用电穿孔法制备了CGRP基因转染DC。结果表明,CGRP基因-β-DC能抑制EAU的发生,并能抑制IRBP-p特异性的DH,证明CGRP和CGRP基因-β-DC对EAU的发生具有免疫抑制作用,其作用优于TGF-β_2。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Possibility of inducing anterior chamber-associated immune deviation by TGF-β2 treatment of monocytes isolated from Behcets patients.
通过 TGF-β2 处理从 Behcets 患者分离的单核细胞诱导前房相关免疫偏差的可能性。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takeuchi M.;Keino H.;Suzuki J.;Usui Y.;Hattori T.;Takeuchi A.;Oh-i K.;Okunuki Y.;Kezuka T.;Usui M.
  • 通讯作者:
    Usui M.
Intravitoreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in rats.
玻璃体内注射他克莫司 (FK506) 可抑制大鼠正在进行的实验性自身免疫性葡萄膜视网膜炎。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Oh-i K.;Keino H.;Goto H.;Yamakawa N.;Murase K.;Usui Y.;Kezuka T.;Sakai J.;Takeuchi M.;Usui M.
  • 通讯作者:
    Usui M.
Acute retinal necrosis.Immune Response and the Eye. Chem Immunol Allergy 92(Niederkorn JY, Kaplan HJ (eds))
急性视网膜坏死。免疫反应和眼睛。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kezuka T.;Atherton SS.(分担執筆)
  • 通讯作者:
    Atherton SS.(分担執筆)
The role of the ICOS/B7RP‐1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis
  • DOI:
    10.1002/eji.200636138
  • 发表时间:
    2006-11
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura
  • 通讯作者:
    Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura
Kaplan HJ (eds) : Immune Response and the Eye.
Kaplan HJ(编辑):免疫反应和眼睛。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kezuka T.;Atherton SS.Acute retinal necrosis.Niederkorn JY
  • 通讯作者:
    Atherton SS.Acute retinal necrosis.Niederkorn JY
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEZUKA Takeshi其他文献

KEZUKA Takeshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEZUKA Takeshi', 18)}}的其他基金

Suppression of murine experimental autoimmune optic neuritis byinnovation of mature dendritic cells transfected with calcitoningene-related peptide gene
转染降钙素基因相关肽基因的成熟树突状细胞创新抑制小鼠实验性自身免疫性视神经炎
  • 批准号:
    22591967
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of CGRP-gene-transfected immune regulatory cells for treatment of refractory uveoretinitis in human
开发CGRP基因转染的免疫调节细胞用于治疗人类难治性葡萄膜视网膜炎
  • 批准号:
    19592041
  • 财政年份:
    2007
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
Optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis
优化甲氨蝶呤的使用以治疗慢性儿科非感染性葡萄膜炎
  • 批准号:
    10568202
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Mechanisms of immunological memory-mediated pathogenesis in chronic autoimmune uveitis
慢性自身免疫性葡萄膜炎免疫记忆介导的发病机制
  • 批准号:
    10657851
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of CDCP1 in the pathogenesis of autoimmune uveitis
CDCP1在自身免疫性葡萄膜炎发病机制中的作用
  • 批准号:
    10655755
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Development of a new diagnostic method for uveitis using artificial intelligence and omics analysis
利用人工智能和组学分析开发葡萄膜炎新诊断方法
  • 批准号:
    22K09840
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis
眼归巢肽的鉴定及其在后葡萄膜炎靶向脂质体药物递送中的应用
  • 批准号:
    10612913
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Identification of eye-homing peptides and their use for targeted liposomal drug delivery in posterior uveitis
眼归巢肽的鉴定及其在后葡萄膜炎靶向脂质体药物递送中的应用
  • 批准号:
    10452321
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Objective Measures of Intraocular Inflammation in Pediatric Anterior Uveitis
小儿前葡萄膜炎眼内炎症的客观测量
  • 批准号:
    10462742
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis
肠道 T 细胞和微生物群作为自身免疫性葡萄膜炎的治疗靶点
  • 批准号:
    10275312
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
Development of a new drug for treating autoimmune uveitis
治疗自身免疫性葡萄膜炎新药的研制
  • 批准号:
    10321980
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了